Cecilia Bonazzetti

1.5k total citations
37 papers, 420 citations indexed

About

Cecilia Bonazzetti is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cecilia Bonazzetti has authored 37 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cecilia Bonazzetti's work include COVID-19 Clinical Research Studies (9 papers), Antibiotic Use and Resistance (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Cecilia Bonazzetti is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Antibiotic Use and Resistance (7 papers) and Antibiotic Resistance in Bacteria (6 papers). Cecilia Bonazzetti collaborates with scholars based in Italy, Spain and South Africa. Cecilia Bonazzetti's co-authors include Spinello Antinori, Anna Lisa Ridolfo, Laura Galimberti, Valentina Morena, Andrea Giacomelli, Sara Giordana Rimoldi, Cristina Pagani, Amedeo Capetti, G. Gubertini and Piercarlo Sarzi‐Puttini and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Cecilia Bonazzetti

32 papers receiving 415 citations

Peers

Countries citing papers authored by Cecilia Bonazzetti

Since Specialization

Citations

This map shows the geographic impact of Cecilia Bonazzetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Bonazzetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Bonazzetti more than expected).

Fields of papers citing papers by Cecilia Bonazzetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Bonazzetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Bonazzetti. The network helps show where Cecilia Bonazzetti may publish in the future.

Co-authorship network of co-authors of Cecilia Bonazzetti

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Bonazzetti. A scholar is included among the top collaborators of Cecilia Bonazzetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Bonazzetti. Cecilia Bonazzetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 2025 ·npj Digital Medicine ·Cecilia Bonazzetti, (unknown), (unknown), (unknown), Claudia Sala, Renato Pascale, Matteo Rinaldi, Caterina Campoli, Zeno Pasquini, (unknown), (unknown), Milo Gatti, Simone Ambretti, Pierluigi Viale, Gastone Castellani, Maddalena Giannella	2
2	Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 2025 ·Journal of Antimicrobial Chemotherapy ·Matteo Rinaldi, Ilaria Rancan, (unknown), Milo Gatti, (unknown), (unknown), Caterina Campoli, Cecilia Bonazzetti, (unknown), Natascia Caroccia, Simone Ambretti, Mario Tumbarello, (unknown), Maddalena Giannella	0
3	ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases 2025 ·Clinical Microbiology and Infection ·(unknown), Pedro Navarro, Cecilia Bonazzetti, Caterina Campoli, Alessia Savoldi, Elisa Gentilotti, Antonella d'Arminio Monforte, Sergio Lo Caputo, (unknown), Isabel Castrejón, Evelina Tacconelli, Jesús Rodríguez‐Baño, Zaira R. Palacios‐Baena, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
4	HHV8-related diseases in solid organ transplantation: a case series and systematic literature review 2025 ·Clinical Microbiology and Infection ·Cecilia Bonazzetti, Matteo Rinaldi, F Giovagnorio, (unknown), (unknown), Alessandra Cascavilla, Maria Cristina Morelli, Luca Vizioli, (unknown), Giorgia Comai, (unknown), Luciano Potena, Liliana Gabrielli, Tiziana Lazzarotto, (unknown), Pierluigi Viale, Maddalena Giannella	1
5	Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 2025 ·The Lancet Infectious Diseases ·(unknown), Elisabetta Manaresi, Gisella Vischini, Michele Provenzano, Valeria Corradetti, Maddalena Giannella, Cecilia Bonazzetti, Matteo Rinaldi, (unknown), Matteo Ravaioli, Giorgio Gallinella, Gaetano La Manna, Giorgia Comai	1
6	Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study 2025 ·The Journal of Infectious Diseases ·Milo Gatti, Matteo Rinaldi, Cristiana Laici, Cecilia Bonazzetti, Luca Vizioli, Simone Ambretti, Maria Cristina Morelli, Antonio Daniele Pinna, Maddalena Giannella, Pierluigi Viale, Federico Pea	1
7	A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar? 2025 ·Journal of Antimicrobial Chemotherapy ·Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, Antonio Daniele Pinna, Tommaso Tonetti, Simone Ambretti, Maddalena Giannella, Pierluigi Viale, Federico Pea	2
8	Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 2024 ·Microorganisms ·Milo Gatti, Cecilia Bonazzetti, Renato Pascale, Maddalena Giannella, Pierluigi Viale, Federico Pea	2
9	Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria 2024 ·Transplant Infectious Disease ·Cecilia Bonazzetti, Matteo Rinaldi, Federica Cosentino, Milo Gatti, Maristela Pinheiro Freire, Alessandra Mularoni, Wanessa Trindade Clemente, Lı́gia Camera Pierrotti, José María Aguado, Paolo Grossi, Federico Pea, Pierluigi Viale, Maddalena Giannella, (unknown)	2
10	Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves 2023 ·Antibiotics ·(unknown), Giacomo Casalini, (unknown), Andrea Giacomelli, (unknown), (unknown), (unknown), (unknown), Letizia Oreni, Laura Galimberti, Riccardo Colombo, Giuliano Rizzardini, Cristina Pagani, Sara Giordana Rimoldi, Cecilia Bonazzetti, Anna Lisa Ridolfo, Spinello Antinori	3
11	Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 2023 ·Microorganisms ·Marco Masetti, (unknown), (unknown), L. Giovannini, (unknown), (unknown), (unknown), Renato Pascale, Cecilia Bonazzetti, Natascia Caroccia, (unknown), Giosafat Spitaleri, Pierluigi Viale, Maddalena Giannella, Luciano Potena	3
12	Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 2023 ·International Journal of Antimicrobial Agents ·Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, Natascia Caroccia, Milo Gatti, (unknown), (unknown), Maddalena Giannella, Pierluigi Viale	4
13	Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 2023 ·Clinical Microbiology and Infection ·Milo Gatti, Cecilia Bonazzetti, (unknown), Renato Pascale, (unknown), (unknown), (unknown), (unknown), Matteo Rinaldi, Pierluigi Viale, Maddalena Giannella	21
14	The controversial bond between COVID-19 and bacterial superinfections 2023 ·Clinical Microbiology and Infection ·Cecilia Bonazzetti, Maddalena Giannella	2
15	Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 2023 ·BMC Infectious Diseases ·Matteo Rinaldi, Caterina Campoli, (unknown), (unknown), Alberto Zuppiroli, Riccardo Riccardi, (unknown), (unknown), (unknown), Cecilia Bonazzetti, Renato Pascale, (unknown), Zeno Pasquini, Lorenzo Marconi, Stefania Curti, Maddalena Giannella, Pierluigi Viale	1
16	Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 2022 ·Infection ·Cecilia Bonazzetti, Matteo Rinaldi, Andrea Giacomelli, Riccardo Colombo, Davide Ottolina, Sara Giordana Rimoldi, Cristina Pagani, Valentina Morena, Anna Lisa Ridolfo, Oana Vatamanu, (unknown), Caterina Campoli, Letizia Oreni, Giuliano Rizzardini, Pierluigi Viale, Spinello Antinori, Maddalena Giannella	7
17	Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 2021 ·Journal of Endocrinological Investigation ·Dario Cattaneo, Luca Pasina, Federico Conti, Andrea Giacomelli, Letizia Oreni, Laura Pezzati, Cecilia Bonazzetti, Marco Piscaglia, (unknown), Spinello Antinori, Cristina Gervasoni	3
18	Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge 2020 ·Travel Medicine and Infectious Disease ·Spinello Antinori, Roberto Rech, Laura Galimberti, Antonio Castelli, Elena Angeli, Tommaso Fossali, Davide Paolo Bernasconi, Alice Covizzi, Cecilia Bonazzetti, Alessandro Torre, Luca Carsana, Cristina Tonello, Pietro Zerbi, Manuela Nebuloni	45
19	Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients 2020 ·European Journal of Internal Medicine ·Laura Milazzo, Lorena van den Bogaart, Salvatore Sollima, Letizia Oreni, Alessia Lai, Valentina Morena, Cecilia Bonazzetti, (unknown), Spinello Antinori	1
20	Trypanosoma cruziinfection in Latin American pregnant women living outside endemic countries and frequency of congenital transmission: a systematic review and meta-analysis 2020 ·Journal of Travel Medicine ·Valeria Colombo, Andrea Giacomelli, Giovanni Casazza, Laura Galimberti, Cecilia Bonazzetti, (unknown), Anna Lisa Ridolfo, Spinello Antinori	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact